echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Digestive System Information > Nat Commun: Clinical trials have confirmed that the natural product berberine regulates insulin secretion and treats diabetes

    Nat Commun: Clinical trials have confirmed that the natural product berberine regulates insulin secretion and treats diabetes

    • Last Update: 2021-09-28
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Natural plants are a rich source of new drugs


    Natural plants are a rich source of new drugs


    Recently, researchers reported on the effect of berberine (BBR) on stimulating insulin secretion


    Recently, researchers reported on the effect of berberine (BBR) on stimulating insulin secretion


    Further studies have shown that BBR directly binds to KCNH6 potassium channels, significantly accelerating channel closure and subsequently reducing KCNH6 currents


    Berberine increases the secretion of highly glucose-dependent insulin

    Berberine increases the secretion of high glucose-dependent insulin Berberine increases the secretion of high glucose-dependent insulin

    Finally, in order to evaluate the effect of BBR on human insulin secretion, the researchers conducted a randomized, double-blind, placebo-controlled, two-phase crossover, single-dose Phase 1 clinical trial (NCT03972215), which included 15 healthy men who received 160 minutes hyperglycemia clamp experiment


    Finally, in order to evaluate the effect of BBR on human insulin secretion, the researchers conducted a randomized, double-blind, placebo-controlled, two-phase crossover, single-dose Phase 1 clinical trial (NCT03972215), which included 15 healthy men who received 160 minutes hyperglycemia clamp experiment


    The results show that, compared with placebo treatment, BBR can significantly promote insulin secretion in a hyperglycemic state without affecting the body's basal insulin secretion


    Thus, in this study, researchers found that a BBR for glucose-dependent insulin secretagogue KCNH6 channels, for the treatment of diabetes without causing hypoglycemia


    Original source:

    Original source: Original source:

    Miao-Miao Zhao et al.


    Miao-Miao Zhao et al.


     



    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.